Works by Ansell, Stephen

Results: 264
    1

    Incidental vs. symptomatic diagnosis of follicular lymphoma: implications of earlier detection.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01322-9
    By:
    • Atallah-Yunes, Suheil Albert;
    • Rees, Matthew J.;
    • Mwangi, Raphael;
    • Kuchler, Robyn L.;
    • Alnughmush, Ahmed;
    • Nowakowski, Grzegorz S.;
    • Habermann, Thomas M.;
    • Wang, Yucai;
    • Villasboas Bisneto, Jose C.;
    • Feldman, Andrew L.;
    • Maurer, Matthew J.;
    • Cerhan, James R.;
    • Ansell, Stephen M.;
    • Witzig, Thomas E.
    Publication type:
    Article
    2

    Long‐term outcome of immunologic autograft engineering.

    Published in:
    EJHaem, 2022, v. 3, n. 2, p. 488, doi. 10.1002/jha2.404
    By:
    • Porrata, Luis F.;
    • Inwards, David J.;
    • Ansell, Stephen M.;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Villasboas, Jose C.;
    • Paludo, Jonas;
    • Markovic, Svetomir N.
    Publication type:
    Article
    3
    4
    5

    CD40 Pathway Activation Status Predicts Response to CD40 Therapy in Diffuse Large B Cell Lymphoma.

    Published in:
    Science Translational Medicine, 2011, v. 3, n. 74, p. 1, doi. 10.1126/scitranslmed.3001620
    By:
    • Burington, Bart;
    • Yue, Peng;
    • Shi, Xiaoyan;
    • Advani, Ranjana;
    • Lau, Jeffrey T.;
    • Tan, Jenille;
    • Stinson, Susanna;
    • Stinson, Jeremy;
    • Januario, Thomas;
    • Vos, Sven de;
    • Ansell, Stephen;
    • Forero-Torres, Andres;
    • Fedorowicz, Grazyna;
    • Yang, Teddy T. C.;
    • Elkins, Kristi;
    • Du, Changchun;
    • Mohan, Sankar;
    • Yu, Nancy;
    • Modrusan, Zora;
    • Seshagiri, Somasekar
    Publication type:
    Article
    6
    7
    8

    Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome.

    Published in:
    European Journal of Haematology, 2008, v. 80, n. 5, p. 397, doi. 10.1111/j.1600-0609.2008.01037.x
    By:
    • Dispenzieri, Angela;
    • Lacy, Martha Q.;
    • Hayman, Suzanne R.;
    • Kumar, Shaji K.;
    • Buadi, Francis;
    • Dingli, David;
    • Litzow, Mark R.;
    • Gastineau, Dennis A.;
    • Inwards, David J.;
    • Elliott, Michelle A.;
    • Micallef, Ivana N.;
    • Ansell, Stephen M.;
    • Hogan, William J.;
    • Porrata, Luis F.;
    • Johnston, Patrick A.;
    • Afessa, Bekele;
    • Bryce, Alan;
    • Kyle, Robert A.;
    • Gertz, Morie A.
    Publication type:
    Article
    9
    10
    11

    A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors.

    Published in:
    Journal of Hematology & Oncology, 2014, v. 7, n. 1, p. 3, doi. 10.1186/1756-8722-7-44
    By:
    • de Vos, Sven;
    • Forero-Torres, Andres;
    • Ansell, Stephen M.;
    • Kahl, Brad;
    • Cheson, Bruce D.;
    • Bartlett, Nancy L.;
    • Furman, Richard R.;
    • Winter, Jane N.;
    • Kaplan, Henry;
    • Timmerman, John;
    • Whiting, Nancy C.;
    • Drachman, Jonathan G.;
    • Advani, Ranjana
    Publication type:
    Article
    12
    13

    Autologous Transplant or CAR‐T as Consolidation Options in MYC Rearranged Large B‐Cell Lymphoma Patients in Remission After Salvage Treatments.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 7, p. 1152, doi. 10.1002/ajh.27687
    By:
    • Furqan, Fateeha;
    • Ahn, Kwang W.;
    • Kaur, Manmeet;
    • Patel, Jinalben;
    • Ansell, Stephen;
    • Awan, Farrukh T.;
    • Baird, John;
    • Bezerra, Evandro;
    • Farooq, Umar;
    • Fung, Henry;
    • Khurana, Arushi;
    • Lekakis, Lazaros;
    • Lutfi, Forat;
    • McCarty, John;
    • Mukherjee, Akash;
    • Nath, Rajneesh;
    • Romancik, Jason;
    • Schuster, Stephen J.;
    • Smith, Melody;
    • Winter, Allison
    Publication type:
    Article
    14
    15
    16

    Checkpoint inhibitor‐based salvage regimens prior to autologous stem cell transplant improve event‐free survival in relapsed/refractory classic Hodgkin lymphoma.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 3, p. 464, doi. 10.1002/ajh.26827
    By:
    • Desai, Sanjal H.;
    • Spinner, Michael A.;
    • David, Kevin;
    • Bachanova, Veronika;
    • Goyal, Gaurav;
    • Kahl, Brad;
    • Dorritie, Kathleen;
    • Azzi, Jacques;
    • Kenkre, Vaishalee P.;
    • Arai, Sally;
    • Chang, Cheryl;
    • Fusco, Brendon;
    • Sumransub, Nuttavut;
    • Hatic, Haris;
    • Saba, Raya;
    • Ibrahim, Uroosa;
    • Harris, Elyse I.;
    • Shah, Harsh;
    • Murphy, Jacob;
    • Ansell, Stephen
    Publication type:
    Article
    17

    Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 3, p. 432, doi. 10.1002/ajh.26807
    By:
    • Chohan, Karan L.;
    • Paludo, Jonas;
    • Vallumsetla, Nishanth;
    • Larson, Dirk;
    • King, Rebecca L.;
    • He, Rong;
    • Gonsalves, Wilson;
    • Inwards, David;
    • Witzig, Thomas E.;
    • Swaika, Abhisek;
    • Jain, Tania;
    • Leung, Nelson;
    • Ailawadhi, Sikander;
    • Reeder, Craig B.;
    • Lacy, Martha Q.;
    • Rajkumar, S. Vincent;
    • Kumar, Shaji;
    • Kyle, Robert A.;
    • Gertz, Morie A.;
    • Ansell, Stephen M.
    Publication type:
    Article
    18

    Clinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003–2018).

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 9, p. 1150, doi. 10.1002/ajh.26635
    By:
    • Seegobin, Karan;
    • Li, Zhuo;
    • Alhaj Moustafa, Muhamad;
    • Majeed, Umair;
    • Wang, Jing;
    • Jiang, Liuyan;
    • Kuhlman, Justin;
    • Menke, David;
    • Li, Ke;
    • Kharfan‐Dabaja, Mohamed A.;
    • Ayala, Ernesto;
    • Iqbal, Madiha;
    • Nowakowski, Grzegorz S.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Johnston, Patrick;
    • Thompson, Carrie;
    • Ansell, Stephen;
    • Tun, Han W.
    Publication type:
    Article
    19

    Peak absolute lymphocyte count after CAR‐T infusion predicts clinical response in aggressive lymphoma.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 7, p. E241, doi. 10.1002/ajh.26561
    By:
    • Bansal, Radhika;
    • Novo, Mattia;
    • Al Saleh, Abdullah S.;
    • Guerrico, Anatilde Gonzalez;
    • Zhang, Henan;
    • Shao, Zuoyi;
    • Babadi, Elham;
    • Martinez, Kodi E.;
    • McCoy, Gabrielle A.;
    • Hathcock, Matthew A.;
    • Khurana, Arushi;
    • Bennani, Nabila Nora;
    • Paludo, Jonas;
    • Wang, Yucai;
    • Ansell, Stephen M.;
    • Johnston, Patrick B.;
    • Villasboas, Jose C.;
    • Lin, Yi
    Publication type:
    Article
    20
    21
    22

    Lines of therapy before autologous stem cell transplant and CAR‐T affect outcomes in aggressive Non‐Hodgkin's lymphoma.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 10, p. E386, doi. 10.1002/ajh.26293
    By:
    • Khurana, Arushi;
    • Hathcock, Matthew;
    • Habermann, Thomas M.;
    • Al Saleh, Abdullah S.;
    • Gandhi, Sangeetha;
    • Truong, Tuan;
    • Bennani, N. Nora;
    • Paludo, Jonas;
    • Villasboas, Jose C.;
    • Ansell, Stephen M.;
    • Inwards, David J.;
    • Porrata, Luis F.;
    • Johnston, Patrick B.;
    • Micallef, Ivana;
    • Lin, Yi
    Publication type:
    Article
    23

    Assessment of fixed‐duration therapies for treatment‐naïve Waldenström macroglobulinemia.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. 945, doi. 10.1002/ajh.26210
    By:
    • Abeykoon, Jithma P.;
    • Zanwar, Saurabh;
    • Ansell, Stephen M.;
    • Muchtar, Eli;
    • He, Rong;
    • Greipp, Patricia T.;
    • King, Rebecca L.;
    • Ailawadhi, Sikander;
    • Paludo, Jonas;
    • Larsen, Jeremy T.;
    • Habermann, Thomas M.;
    • Inwards, David;
    • Go, Ronald S.;
    • Thanarajasingam, Gita;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Thompson, Carrie A.;
    • Witzig, Thomas E.;
    • Lacy, Martha;
    • Gonsalves, Wilson
    Publication type:
    Article
    24
    25
    26

    Prevalence, clinical characteristics and prognosis of EBV‐positive follicular lymphoma.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 2, p. E62, doi. 10.1002/ajh.25357
    By:
    • Mackrides, Nicholas;
    • Chapman, Jennifer;
    • Larson, Melissa C.;
    • Ramos, Juan C.;
    • Toomey, Ngoc;
    • Lin, Pei;
    • Maurer, Matthew J.;
    • Rafaelle, Myra;
    • Tan, Yaohong;
    • Ikpatt, Offiong;
    • Syrbu, Sergei;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Link, Brian K.;
    • Feldman, Andrew L.;
    • Lossos, Izidore S.;
    • Cerhan, James R.;
    • Vega, Francisco
    Publication type:
    Article
    27

    Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 11, p. 1384, doi. 10.1002/ajh.25254
    By:
    • Abeykoon, Jithma P.;
    • Zanwar, Saurabh;
    • Ansell, Stephen M.;
    • Winters, Jeffrey;
    • Gertz, Morie A.;
    • King, Rebecca L.;
    • Murray, David;
    • Habermann, Thomas;
    • Dingli, David;
    • Muchtar, Eli;
    • Go, Ronald S.;
    • Leung, Nelson;
    • Inwards, David J;
    • Buadi, Francis K.;
    • Dispenzieri, Angela;
    • Lacy, Martha Q.;
    • Lin, Yi;
    • Gonsalves, Wilson I.;
    • Kourelis, Taxiarchis;
    • Witzig, Thomas E.
    Publication type:
    Article
    28
    29

    Reply to Castillo et al.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 3, p. E71, doi. 10.1002/ajh.25029
    By:
    • Abeykoon, Jithma P.;
    • King, Rebecca;
    • Ansell, Stephen M.;
    • Rajkumar, S. Vincent;
    • Paludo, Jonas;
    • Kyle, Robert A.;
    • Kumar, Shaji;
    • Gertz, Morie A.;
    • Kapoor, Prashant
    Publication type:
    Article
    30

    <italic>MYD88</italic> mutation status does not impact overall survival in Waldenström macroglobulinemia.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 2, p. 187, doi. 10.1002/ajh.24955
    By:
    • Abeykoon, Jithma P.;
    • Paludo, Jonas;
    • King, Rebecca L.;
    • Ansell, Stephen M.;
    • Gertz, Morie A.;
    • LaPlant, Betsy R.;
    • Halvorson, Alese E.;
    • Gonsalves, Wilson I.;
    • Dingli, David;
    • Fang, Hong;
    • Rajkumar, S. Vincent;
    • Lacy, Martha Q.;
    • He, Rong;
    • Kourelis, Taxiarchis;
    • Reeder, Craig B.;
    • Novak, Anne J.;
    • McPhail, Ellen D.;
    • Viswanatha, David S.;
    • Witzig, Thomas E.;
    • Go, Ronald S.
    Publication type:
    Article
    31
    32

    Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 5, p. 448, doi. 10.1002/ajh.24671
    By:
    • Bennani, N. Nora;
    • LaPlant, Betsy R.;
    • Ansell, Stephen M.;
    • Habermann, Thomas. M.;
    • Inwards, David J.;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Porrata, Luis F.;
    • Colgan, Joseph P.;
    • Markovic, Svetomir N.;
    • Nowakowski, Grzegorz S.;
    • Macon, William R.;
    • Reeder, Craig B.;
    • Mikhael, Joseph R.;
    • Northfelt, Donald W.;
    • Ghobrial, Irene M.;
    • Witzig, Thomas E.
    Publication type:
    Article
    33

    A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 5, p. 467, doi. 10.1002/ajh.24693
    By:
    • Rosenthal, Allison;
    • Dueck, Amylou C.;
    • Ansell, Stephen;
    • Gano, Katherine;
    • Conley, Christopher;
    • Nowakowski, Grzegorz S.;
    • Camoriano, John;
    • Leis, Jose F.;
    • Mikhael, Joseph R.;
    • Keith Stewart, A.;
    • Inwards, David;
    • Dingli, David;
    • Kumar, Shaji;
    • Noel, Pierre;
    • Gertz, Morie;
    • Porrata, Luis;
    • Russell, Stephen;
    • Colgan, Joseph;
    • Fonseca, Rafael;
    • Habermann, Thomas M.
    Publication type:
    Article
    34

    Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.

    Published in:
    American Journal of Hematology, 2016, v. 91, n. 11, p. 1096, doi. 10.1002/ajh.24492
    By:
    • Maurer, Matthew J.;
    • Bachy, Emmanuel;
    • Ghesquières, Hervé;
    • Ansell, Stephen M.;
    • Nowakowski, Grzegorz S.;
    • Thompson, Carrie A.;
    • Inwards, David J.;
    • Allmer, Cristine;
    • Chassagne-Clément, Catherine;
    • Nicolas-Virelizier, Emmanuelle;
    • Sebban, Catherine;
    • Lebras, Laure;
    • Sarkozy, Clementine;
    • Macon, William R.;
    • Feldman, Andrew L.;
    • Syrbu, Sergei I.;
    • Traverse-Glehan, Alexandra;
    • Coiffier, Bertrand;
    • Slager, Susan L.;
    • Weiner, George J.
    Publication type:
    Article
    35
    36
    37
    38
    39

    Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non- Hodgkin lymphoma.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 12, p. 1116, doi. 10.1002/ajh.23839
    By:
    • Witzig, Thomas E.;
    • Maurer, Matthew J.;
    • Habermann, Thomas M.;
    • Link, Brian K.;
    • Micallef, Ivana N.M.;
    • Nowakowski, Grzegorz S.;
    • Ansell, Stephen M.;
    • Colgan, Joseph P.;
    • Inwards, David J.;
    • Porrata, Luis F.;
    • Markovic, Svetomir N.;
    • Johnston, Patrick B.;
    • Lin, Yi;
    • Thompson, Carrie;
    • Gupta, Mamta;
    • Katzmann, Jerry A.;
    • Cerhan, James R.
    Publication type:
    Article
    40
    41

    A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and <sup>90</sup>yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma.

    Published in:
    American Journal of Hematology, 2013, v. 88, n. 7, p. 589, doi. 10.1002/ajh.23460
    By:
    • Witzig, Thomas E.;
    • Wiseman, Gregory A.;
    • Maurer, Matthew J.;
    • Habermann, Thomas M.;
    • Micallef, Ivana N.M.;
    • Nowakowski, Grzegorz S.;
    • Ansell, Stephen M.;
    • Colgan, Joseph P.;
    • Inwards, David J.;
    • Porrata, Luis F.;
    • Link, Brian K.;
    • Zent, Clive S.;
    • Johnston, Patrick B.;
    • Shanafelt, Tait D.;
    • Allmer, Cristine;
    • Asmann, Yan W.;
    • Gupta, Mamta;
    • Ballas, Zuhair K.;
    • Smith, Brian J.;
    • Weiner, George J.
    Publication type:
    Article
    42
    43
    44
    45
    46
    47

    The definition of IgM multiple myeloma.

    Published in:
    American Journal of Hematology, 2011, v. 86, n. 8, p. 718, doi. 10.1002/ajh.22080
    By:
    • Schuster, Steven R.;
    • Rajkumar, S. Vincent;
    • Dispenzieri, Angela;
    • Morice, William;
    • Aspitia, Alvaro Moreno;
    • Ansell, Stephen;
    • Kyle, Robert;
    • Mikhael, Joseph
    Publication type:
    Article
    48
    49
    50

    A Phase II study of <sup>153</sup>Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.

    Published in:
    American Journal of Hematology, 2010, v. 85, n. 6, p. 409, doi. 10.1002/ajh.21696
    By:
    • Dispenzieri, Angela;
    • Wiseman, Gregory A.;
    • Lacy, Martha Q.;
    • Hayman, Suzanne R.;
    • Kumar, Shaji K.;
    • Buadi, Francis;
    • Dingli, David;
    • Laumann, Krista M.;
    • Allred, Jake;
    • Geyer, Susan M.;
    • Litzow, Mark R.;
    • Gastineau, Dennis A.;
    • Inwards, David J.;
    • Micallef, Ivana N.;
    • Ansell, Stephen M.;
    • Porrata, Luis;
    • Elliott, Michelle A.;
    • Johnston, Patrick B.;
    • Hogan, William J.;
    • Gertz, Morie A.
    Publication type:
    Article